NCT04480814 2025-12-30
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
Pharmassist Ltd
Completed
Pharmassist Ltd
Novartis
Novartis
AstraZeneca
British Columbia Cancer Agency
Fudan University